25(OH)D Levels in Relation to Gender, Overweight, Insulin Resistance, and Inflammation in a Cross-Sectional Cohort of Northern Italian Workers: Evidence in Support of Preventive Health Care Programs

Journal of the American College of Nutrition

Volumn 36, Issue 4, 2017, Pages 253-260

  Vigna, Luisella ^a   Cassinelli, Letizia ^a   Tirelli, Amedea Silvia ^a   Felicetta, Irene ^b   Napolitano, Filomena ^b   Tomaino, Laura ^a,c   Mutti, Michela ^b   Barberi, Claudia Eleonora ^a   Riboldi, Luciano ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Bacteriology and Virology Units ^*  (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

fatty liver index; Insulin resistance; metabolic syndrome; obesity; occupational; preventative nutrition and chronic disease; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; TRIACYLGLYCEROL; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; GENDER; HUMAN; IMPEDANCE; INFLAMMATION; INSULIN RESISTANCE; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; OCCUPATIONAL MEDICINE; PHYSICAL ACTIVITY; PREVENTIVE MEDICINE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; ITALY; PREVENTIVE HEALTH SERVICE; SEX FACTOR;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; ITALY; MALE; MIDDLE AGED; OVERWEIGHT; PREVENTIVE HEALTH SERVICES; SEX FACTORS; VITAMIN D;

EID: 85018173895     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2016.1264280     Document Type: Article

References (62)

1. Korpela K, Roos E, Lallukka T, Rahkonen O, Lahelma E, Laaksonen M, :Different measures of body weight as predictors of sickness absence. Scand J Public Health 41:25–31, 2013.
2. Mummery WK, Schofield GM, Steele R, Eakin EG, Brown WJ, :Occupational sitting time and overweight and obesity in Australian workers. Am J Prev Med 29:91–97, 2005.
3. Gallus S, Odone A, Lugo A, Bosetti C Colombo P, Zuccaro P, La Vecchia C, :Overweight and obesity prevalence and determinants in Italy:an update to 2010. Eur J Nutr 52:677–685, 2013.
4. Holick MF, :The role of Vitamin D for bone health and fracture prevention. Curr Osteoporos Rep 4:98–102, 2006.
5. Ganji V, Zhang X, Shaikh N, Tangpricha V, :Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in U.S. children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001–2006. Am J Clin Nutr 94:225–233, 2011.
6. Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, Lawless A, :Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 3:289–296, 2009.
7. Ganji V, Milone C, Cody MM, McCarty F, Wang YT, :Serum vitamin D concentrations are related to depression in young adult U.S. population:the Third National Health and Nutrition Examination Survey. Int Arch Med 3:29, 2010.
8. Arnson Y, Amital H, Shoenfeld Y, :Vitamin D and autoimmunity:new etiological and therapeutic considerations. Ann Rheum Dis 66:1137–1142, 2007.
9. Hewison M, :Vitamin D and immune function:an overview. Proc Nutr Soc 71:50–61, 2012.
10. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF, :Vitamin D and cancer. Anticancer Res 26:2515–2524, 2006.
11. Bakhru A, Mallinger JB, Buckanovich RJ, Griggs JJ, :Casting light on 25 hydroxyvitamin D deficiency in ovarian cancer:a study from the NHANES. Gynecol Oncol 119:314–318, 2010.
12. Giovannucci E, Liu Y, Hollis BW, Rimm EB, :25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 168:1174–1180, 2008.
13. Reis JP, Von Muhlen D, Miller ER, III, Michos ED, Appel LJ, :Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 124:371–379, 2009.
14. Fiscella K, Franks P, :Vitamin D, race, and cardiovascular mortality:findings from a national U.S. sample. Ann Fam Med 8:11–18, 2010.
15. Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V, :Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans:results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 87:136–141, 2008.
16. Zhao G, Ford ES, Li C, Kris-Etherton PM, Etherton TD, Balluz LS, :Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among U.S. adults. J Hypertens 28:1821–1828, 2010.
17. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN, :Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London:a case–control study. Lancet 355:618–621, 2000.
18. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T, :An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86:714–717, 2007.
19. Earthman CP, Beckman LM, Masodkar K, Sibley SD, :The link between obesity and low circulating 25-hydroxyvitamin D concentrations:considerations and implications. Int J Obes (Lond) 36:387–396, 2012.
20. Lamendola CA, Ariel D, Feldman D, Reaven GM, :Relations between obesity, insulin resistance, and 25-OH vitamin D. Am J Clin Nutr 95:1055–1059, 2012.
21. Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB, Sun Q, Manson JE, :Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 833:2021–2023, 2010.
22. Vierucci F, Del Pistoia M, Fanos M, Gori M, Carlone G, Erba P, Massimetti G, Federico G, Saggese G, :Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents:a cross-sectional study. Eur J Pediatr 172:1607–1617, 2013.
23. Lippi G, Nouvenne A, Ticinesi A, Bonelli P, Salvagno GL, Cervellin G, Guidi GC, :The burden of vitamin D deficiency in a Mediterranean country without a policy of food fortification. Acta Biomed 86:59–62, 2015.
24. Regulation (EC) No. 1893/2006 of the European Parliament and of the Council of 20 December 2006.” Official Journal of the European Union. L. 393/1- 30.12.2006.
25. Tudor-Locke C, Ainsworth BE, Washington TL, Troiano R, :Assigning metabolic equivalent values to the 2002 Census Occupational Classification System. J Phys Act Health 8:581–586, 2011.
26. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association. National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752, 2005.
27. Kahl S, Straßburger K, Nowotny B, Livingstone R, Klüppelholz B, Keßel K, Hwang JH, Giani G, Hoffmann B, Pacini G, Gastaldelli A, Roden M, :Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS One 9:e94059, 2014.
28. Gastaldelli A, Kozakova M, Højlund K, Flyvbjerg A, Favuzzi A, Mitrakou A, Balkau B, and the RISC Investigators:Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537–1544, 2009.
29. Festi D, Colecchia A, Pini S, Scaioli E, Maffeis C, Coccheri S, Petroni ML, :Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians. Med J Nutr Metab 2:139–144, 2009.
30. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, and the Endocrine Society:Evaluation, treatment and prevention of vitamin D deficiency:an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930, 2011.
31. Matthews DR, Hosker JP, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC, :Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985.
32. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C, :The fatty liver index:a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33–39, 2006.
33. Dietary Reference Intakes:Guiding Principles for Nutrition Labeling and Fortification.” 2015 Washington, DC:The National Academies Press, 2003.
34. Varsavsky M, Alonso G, García-Martín A, :Vitamin D:present and future. Rev Clin Esp 214:396–402, 2014.
35. Gröber U, Reichrath J, Holick MF, :Live longer with vitamin D? Nutrients 7:1871–1880, 2015.
36. Baggerly CA, Cuomo RE, French CB, Garland CF, Gorham ED, Grant WB, Heaney RP, Holick MF, Hollis BW, McDonnell SL, Pittaway M, Seaton P, Wagner CL, Wunsch A, :Sunlight and vitamin D:necessary for public health. J Am Coll Nutr 34:359–365, 2015.
37. Lips P, van Schoor NM, de Jongh RT, :Diet, sun, and lifestyle as determinants of vitamin D status. Ann N Y Acad Sci 1317:92–98, 2014.
38. Mangin M, Sinha R, Fincher K, :Inflammation and vitamin D:the infection connection. Inflamm Res 63:803–819, 2014.
39. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, Lips P, :Optimal vitamin D status:a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98:E1283–E1304, 2013.
40. Chao YS, Brunel L, Faris P, Veugelers PJ, :Vitamin D status of Canadians employed in northern latitudes. Occup Med 63:485–493, 2013.
41. Heaney RP, Armas LA, :Screening for vitamin d deficiency:is the goal disease prevention or full nutrient repletion? Ann Intern Med 162:144–145, 2015.
42. Perna L, Haug U, Schöttker B, Müller H, Raum E, Jansen EH, Brenner H, :Public health implications of standardized 25-hydroxyvitamin D levels:a decrease in the prevalence of vitamin D deficiency among older women in Germany. Prev Med 55:228–232, 2012.
43. Bischoff-Ferrari H, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B, :Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28, 2006.
44. Vanlint S, :Vitamin D and obesity. Nutrients 5:949–956, 2013.
45. Bischof MG, Heinze G, Vierhapper H, :Vitamin D status and its relation to age and body mass index. Horm Res 66:211–215, 2006.
46. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF, :Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693, 2000.
47. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, Wood AR, Michaëlsson K, Vandenput L, Zgaga L, Yerges-Armstrong LM, McCarthy MI, Dupuis J, Kaakinen M, Kleber ME, Jameson K, Arden N, Raitakari O, Viikari J, Lohman KK, Ferrucci L, Melhus H, Ingelsson E, Byberg L, Lind L, Lorentzon M, Salomaa V, Campbell H, Dunlop M, Mitchell BD, Herzig KH, Pouta A, Hartikainen AL; Genetic Investigation of Anthropometric Traits-GIANT Consortium., Streeten EA, Theodoratou E, Jula A, Wareham NJ, Ohlsson C, Frayling TM, Kritchevsky SB, Spector TD, Richards JB, Lehtimäki T, Ouwehand WH, Kraft P, Cooper C, März W, Power C, Loos RJ, Wang TJ, Järvelin MR, Whittaker JC, Hingorani AD, Hyppönen E: Causal relationship between obesity and vitamin D status:bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383, 2013.
48. Maxwell CS, Wood RJ, :Update on vitamin D and type 2 diabetes. Nutr Rev 69:291–295, 2011.
49. Barengolts E, :Vitamin D role and use in prediabetes. Endocr Pract 16:476–485, 2010.
50. Dutta D, Maisnam I, Shrivastava A, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P, Mukhopadhyay S, Chowdhury S, :Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res 138:853–860, 2013.
51. Norman PE, Powell JT, :Vitamin D and cardiovascular disease. Circ Res 114:379–393, 2014.
52. Tamez H, Kalim S, Thadani R, :Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens 22:204–209, 2013.
53. Ke L, Mason RS, Kariuki M, Mpofu E, Brock KE, :Vitamin D status and hypertension:a review. Integr Blood Press Control 8:13–35, 2015.
54. Mozos I, Marginean O, :Links between vitamin D deficiency and cardiovascular diseases. Biomed Res Int 109275:2015, 2015.
55. Jorde R, Grimnes G, :Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50:303–312, 2011.
56. Ahern T, Khattak A, O'Malley E, Dunlevy C, Kilbane M, Woods C, McKenna MJ, O'Shea D, :Association between vitamin D status and physical function in the severely obese. J Clin Endocrinol Metab 99:E1327–E1331, 2014.
57. Tepper S, Dabush Y, Shahar DR, Endevelt R, Geva D, Ish-Shalom S, :Vitamin D status and quality of life in healthy male high-tech employees. Nutrients 8:E366, 2016.
58. Khosravi-Boroujeni H, Ahmed F, Sarrafzadegan N, :Is the Association between Vitamin D and Metabolic Syndrome Independent of Other Micronutrients. Int J Vitam Nutr Res 20:1–16, 2016.
59. Dongiovanni P, Lanti C, Riso P, Valenti L, :Nutritional therapy for non-alcoholic fatty liver disease. J Nutr Biochem 29:1–11, 2016.
60. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A, :25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity 18:1906–1910, 2010.
61. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S, :Vitamin D deficiency and mortality risk in the general population:a meta-analysis of prospective cohort studies. Am J Clin Nutr 95:91–100, 2012.
62. Naesgaard PA, León de la Fuente RA, Nilsen ST, Pönitz V, Brügger-Andersen T, Grundt H, Staines H, Nilsen DW, :Suggested cut-off values for vitamin D as a risk marker for total and cardiac death in patients with suspected acute coronary syndrome. Front Cardiovasc Med 26:4, 2016.